Furthermore, apigetrin has been reported to possess potential inhibitory activity against SARS-CoV-2 3-chymotrypsin-like protease (main protease, Mpro) controlling this COVID-19 virus replication and is essential for its life cycle, according to computational analysis, including molecular docking and pharmacokinetic studies69. Here, CTRL is linked to COVID-19.